Injection of antisera into cells to study G-protein regulation of channel function.
McFadzean
I
I
Pharmacology Group, King's College London, United Kingdom.
Caulfield
M P
MP
Vallis
Y
Y
Brown
D A
DA
D000818:Animals; D000906:Antibodies / Q000008:administration & dosage / Q000494:pharmacology*; D002642:Chick Embryo; D004594:Electrophysiology / Q000379:methods; D019204:GTP-Binding Proteins / Q000276:immunology / Q000502:physiology*; D005727:Ganglia, Spinal / Q000502:physiology; D005904:Glial Fibrillary Acidic Protein / Q000276:immunology; D005910:Glioma; D006822:Hybrid Cells; D007106:Immune Sera / Q000008:administration & dosage / Q000494:pharmacology*; D007473:Ion Channels / Q000502:physiology*; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D008839:Microelectrodes; D008845:Microinjections / Q000379:methods; D009447:Neuroblastoma; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D009638:Norepinephrine / Q000494:pharmacology; D011817:Rabbits / Q000276:immunology; D051381:Rats; D017783:Superior Cervical Ganglion / Q000502:physiology
D000906:Antibodies; D005904:Glial Fibrillary Acidic Protein; D007106:Immune Sera; D007473:Ion Channels; D019204:GTP-Binding Proteins; D009638:Norepinephrine